Psychedelics and Mental Health
Explore the groundbreaking research on psychedelics and their potential to reshape neural circuitry, offering hope for treating disorders like depression and trauma. Delve into the differences between microdosing and macro dosing, and gain insights into the experimental processes used in clinical settings. The conversation highlights the evolving landscape of psychedelic therapies and their implications for mental health treatment.In this clip
From this podcast
Huberman Lab
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38
Related Questions
What has Andrew Huberman said about psychedelics for therapy in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics in Research?
What has Andrew Huberman said about psychedelics in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics in Research?
Does Andrew Huberman understand the potential risks of promoting psychedelics to millions in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psilocybin and Innovation, especially considering the possibility of misuse and the current legal status of these substances?